List of Smithkline Beecham Limited patents

Patents where

Current Assignee

Name

Smithkline Beecham Limited

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7429579 Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents)	Patent 7429579 was granted and assigned to Smithkline Beecham Limited on September, 2008 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7429579	September 30, 2008
‌ US Patent RE39576 Enzyme inhibitors	Patent RE39576 was granted and assigned to Smithkline Beecham Limited on April, 2007 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	RE39576	April 17, 2007
‌ US Patent 7166608 None	Patent 7166608 was granted and assigned to Smithkline Beecham Limited on January, 2007 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7166608	January 23, 2007
‌ US Patent 7105529 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects	Patent 7105529 was granted and assigned to Smithkline Beecham Limited on September, 2006 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7105529	September 12, 2006
‌ US Patent 7196107 Thia-and oxazoles and their use as ppars activators	Patent 7196107 was granted and assigned to Smithkline Beecham Limited on March, 2007 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7196107	March 27, 2007
‌ US Patent 7387893 Vectors, cells and processes for pyrimidine deoxyribonucleosides production	Patent 7387893 was granted and assigned to Smithkline Beecham Limited on June, 2008 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7387893	June 17, 2008
‌ US Patent 7456952 System for real-time fluorescent determination of trace elements	Patent 7456952 was granted and assigned to Smithkline Beecham Limited on November, 2008 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7456952	November 25, 2008
‌ US Patent 7238778 Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same	Patent 7238778 was granted and assigned to Smithkline Beecham Limited on July, 2007 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7238778	July 3, 2007
‌ US Patent 7230109 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical	Patent 7230109 was granted and assigned to Smithkline Beecham Limited on June, 2007 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7230109	June 12, 2007
‌ US Patent 7383837 Inhalation device	Patent 7383837 was granted and assigned to Smithkline Beecham Limited on June, 2008 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7383837	June 10, 2008
‌ US Patent 7368574 Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use	Patent 7368574 was granted and assigned to Smithkline Beecham Limited on May, 2008 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7368574	May 6, 2008
‌ US Patent 7358366 Thiazolidinedione derivative and its use as antidiabetic	Patent 7358366 was granted and assigned to Smithkline Beecham Limited on April, 2008 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7358366	April 15, 2008
‌ US Patent 7338966 Substituted oxindole derivatives as tyrosine kinase inhibitors	Patent 7338966 was granted and assigned to Smithkline Beecham Limited on March, 2008 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7338966	March 4, 2008
‌ US Patent RE39384 Substituted thiazolidinedione derivatives	Patent RE39384 was granted and assigned to Smithkline Beecham Limited on November, 2006 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	RE39384	November 7, 2006
‌ US Patent RE40070 Antibody purification	Patent RE40070 was granted and assigned to Smithkline Beecham Limited on February, 2008 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	RE40070	February 19, 2008
‌ US Patent 7563784 Protease inhibitors	Patent 7563784 was granted and assigned to Smithkline Beecham Limited on July, 2009 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7563784	July 21, 2009
‌ US Patent 7168597 Aerosol metering valve	Patent 7168597 was granted and assigned to Smithkline Beecham Limited on January, 2007 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7168597	January 30, 2007
‌ US Patent 7324864 Apparatus and method for measuring forces imparted on valve assemblies of metered dose delivery containers during manufacture thereof	Patent 7324864 was granted and assigned to Smithkline Beecham Limited on January, 2008 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7324864	January 29, 2008
‌ US Patent 7350676 Valve for aerosol container	Patent 7350676 was granted and assigned to Smithkline Beecham Limited on April, 2008 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7350676	April 1, 2008
‌ US Patent 7645771 CCR5 antagonists as therapeutic agents	Patent 7645771 was granted and assigned to Smithkline Beecham Limited on January, 2010 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7645771	January 12, 2010
‌ US Patent 7883721 Pharmaceutical formulation	Patent 7883721 was granted and assigned to Smithkline Beecham Limited on February, 2011 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7883721	February 8, 2011
‌ US Patent 7119092 Chemical compounds	Patent 7119092 was granted and assigned to Smithkline Beecham Limited on October, 2006 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7119092	October 10, 2006
‌ US Patent 7163693 Multi-component pharmaceutical dosage form	Patent 7163693 was granted and assigned to Smithkline Beecham Limited on January, 2007 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7163693	January 16, 2007
‌ US Patent 7091225 Substituted oxazoles and thiazoles as hPPAR alpha agonists	Patent 7091225 was granted and assigned to Smithkline Beecham Limited on August, 2006 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	7091225	August 15, 2006
‌ US Patent 8022032 Method for customized dispensing of variable dose drug combination products for individualizing of therapies	Patent 8022032 was granted and assigned to Smithkline Beecham Limited on September, 2011 by the United States Patent and Trademark Office.	Smithkline Beecham Limited	United States Patent and Trademark Office	8022032	September 20, 2011

...

Results per page:

318 results

0 selected

318 results

0 selected